← Browse by Condition
Medical Condition
advanced gastric cancer
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2
NCT07315854 Phase 2
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
Enrollment
32 pts
Location
China
Sponsor
Beijing Friendship Hospital
NCT07405931
Recruiting
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Enrollment
414 pts
Location
South Korea
Sponsor
Ulsan University Hospital
NCT06727981
Recruiting
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
Enrollment
500 pts
Location
China
Sponsor
Qilu Hospital of Shandong Univ...
NCT06767449
Recruiting
Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer
Enrollment
80 pts
Location
South Korea
Sponsor
Yonsei University